DRAGON PHARMACEUTICALS RECEIVES APPROVAL FROM SHAREHOLDERS IN CONNECTION WITH THE ACQUISITION OF ORIENTAL WAVE HOLDING

Dragon Pharmaceutical has announced that at the annual meeting of shareholders held Jan. 11, the shareholders approved the acquisition by Dragon of Oriental Wave by accepting all the proposals in over 99 percent of the shares represented and voting. More than 82 percent of the outstanding shares were represented at the meeting. In addition, Sun and Wick were re-elected to the board, and Moore Stephen Ellis Foster were ratified to audit the company's financial statements for the year ended Dec. 31, 2004.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18680120&full=1)